Company / Operating Income per Share
BIOCRYST PHARMACEUTICALS INC Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.56
FY2025
5-year range
-$0.99 / $1.56
FY2021-FY2025
Trend
+12779.8%
vs FY2024
Sector context
#36 of 201
Health Care
What the data says
Operating Income per Share changed +12780% YoY in FY2025, a notable deviation from the 9-year average annual change of +1432%.
Based on SEC 10-K filings.
1.56 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.54 to $1.56 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 201This company $1.56 Sector average -$3.23
▼
+148.2% above sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's operating income per share has grown for 5 consecutive years.
- In FY2025, operating income per share increased 12779.8% year-over-year.
- Ranks #36 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +12779.8% |
| FY2024 | -$0.01 | +97.7% |
| FY2023 | -$0.54 | +32.4% |
| FY2022 | -$0.80 | +19.5% |
| FY2021 | -$0.99 | +5.0% |
| FY2020 | -$1.04 | -21.4% |
| FY2019 | -$0.86 | +5.8% |
| FY2018 | -$0.91 | -17.3% |
| FY2017 | -$0.78 | -17.4% |
| FY2016 | -$0.66 | -20.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026